ACI
WX

AMP Capital Investors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

AMP Capital Investors’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-159,992
Closed -$6.92M – 1296
2015
Q3 		$6.92M Sell
159,992
-28,013
-15% -$1.18M 0.05% 378
2015
Q2 		$7.79M Sell
188,005
-65,211
-26% -$2.75M 0.05% 380
2015
Q1 		$9.75M Buy
253,216
+43,982
+21% +$1.69M 0.06% 342
2014
Q4 		$7.06M Buy
209,234
+22,234
+12% +$785K 0.04% 423
2014
Q3 		$6.41M Buy
187,000
+46,700
+33% +$1.6M 0.04% 452
2014
Q2 		$4.68M Buy
140,300
+93,200
+198% +$3.19M 0.03% 531
2014
Q1 		$1.65M Buy
47,100
+2,100
+5% +$77.1K 0.01% 766
2013
Q4 		$1.71M Sell
45,000
-4,600
-9% -$145K 0.01% 758
2013
Q3 		$1.38M Sell
49,600
-15,700
-24% -$372K 0.01% 785
2013
Q2 		$1.35M Buy
+65,300
New +$1.27M 0.01% 822

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

AMP Capital Investors's WX Position: Q4 2015 in Review

AMP Capital Investors sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 159,992 shares — an estimated $6.92M sold.

AMP Capital Investors first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $9.75M in Q1 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • AMP Capital Investors reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • AMP Capital Investors sold 159,992 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $6.92M.
  • AMP Capital Investors first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • AMP Capital Investors's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $9.75M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on AMP Capital Investors's 13F filing for Q4 2015, filed 16 Feb 2016.